ALCL |
anaplastic large cell lymphoma; |
ALL |
acute lymphocytic leukemia |
AML |
acute myeloid leukemia |
AMP |
amplification |
APL |
acute promyelocytic leukemia |
ATLL |
adult T-cell leukemia lymphoma |
B-ALL |
B-cell acute lymphocytic leukemia |
B-NHL |
B-cell non-Hodgkin lymphoma |
BRD |
bromodomain |
CLL |
chronic lymphocytic leukemia |
CML |
chronic myeloid leukemia |
CNA |
copy number alteration |
CRD1 |
cell cycle regulatory domain 1 |
CREBBP |
CREB-binding protein |
DLBCL |
diffuse large B-cell lymphoma |
EP300 |
E1A binding protein p300 |
eRNA |
enhancer RNA |
ESC |
embryonic stem cell |
FL |
follicular lymphoma |
GC |
germinal center |
HAT |
histone acetyltransferase |
HATs |
histone acetyltransferase |
HDACs |
histone deacetylases |
HDACis |
histone deacetylase inhibitors |
HL |
Hodgkin lymphoma |
HOMDEL |
homozygous deletion |
HSCs |
hematopoietic stem cells |
HSPCs |
hematopoietic stem and progenitor cells |
IBiD |
interferon-binding domain |
IMiDs |
immunomodulatory drugs |
KIX |
kinase-inducible domain of CREB interacting domain |
LSTFL |
limited-stage typical follicular lymphoma |
MDS |
myelodysplastic syndrome |
MHC class II |
major histocompatibility complex class II |
MM |
multiple myeloma |
NLS |
nuclear location signal |
NKG2D |
natural-killer group 2 member D |
NRID |
nuclear receptor interaction domain |
PHD |
plant homeodomain |
PTCL |
peripheral T-cell lymphoma |
RING |
really interesting new gene |
T-ALL |
T-cell acute lymphocytic leukemia |
TAZ1 |
transcriptional-adaptor zinc-finger domain 1 |
TAZ2 |
transcriptional-adaptor zinc-finger domain 2 |
Tregs |
T regulatory cells; ZZ: ZZ-type zinc finger. |